Tet1-dCas9 Citations (2)

Originally described in: Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M, O'Geen H, Simion C, Gephart MH, Segal DJ, Sweeney CA Br J Cancer. 2022 Apr 19. pii: 10.1038/s41416-022-01812-8. doi: 10.1038/s41416-022-01812-8. PubMed Journal

---

Articles Citing Tet1-dCas9

Articles
Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility. Rallabandi HR, Singh MK, Looger LL, Nath SK. Int J Mol Sci. 2025 Jan 1;26(1):314. doi: 10.3390/ijms26010314. PubMed
Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for beta-hemoglobinopathies. Amistadi S, Fontana L, Magnoni C, Felix T, Charvin MK, Martinucci P, Gautier C, Greau L, Bessieres B, Antoniou P, Romano O, Allemand E, Mussolino C, Miccio A. Nucleic Acids Res. 2025 Jul 8;53(13):gkaf637. doi: 10.1093/nar/gkaf637. PubMed

If you have published an article using this material, please email us at to have your article added to this page.